• Amanda L Potts, Guy R Warman, and Brian J Anderson.
• University of Auckland, Auckland, New Zealand. a.potts@auckland.ac.nz
• Paediatr Anaesth. 2008 Aug 1;18(8):722-30.

BackgroundThere are few data describing dexmedetomidine population pharmacokinetics (PK) in children (0-15 years) despite increasing use.MethodsAn open-label study was undertaken to examine the PK of i.v. dexmedetomidine 1-4 mug.kg(-1) bolus in children after cardiac surgery (n = 45). A population PK analysis of dexmedetomidine time-concentration profiles (148 observations) was undertaken using nonlinear mixed effects modeling. Estimates were standardized to a 70-kg adult using allometric size models.ResultsChildren had a mean age of 3.38 years (range 4 days to 14 years) and weight 15.1 kg (range 3.1-58.9 kg). A two-compartment disposition model with first order elimination was superior to a one-compartment model. Population parameter estimates (between subject variability) were clearance (CL) 39.2 (CV 30.36%) l.h(-1) per 70 kg, central volume of distribution (V1) 36.9 (69.49%) l per 70 kg, inter-compartment clearance (Q) 68.2 (37.6%) l.h(-1) per 70 kg and peripheral volume of distribution (V2) 69.9 (48.6%) l per 70 kg. Clearance at birth was 15.55 l.h(-1) per 70 kg and matured with a half-time of 46.5 weeks to reach 87% adult rate by 1 year of age. Simulation of an infusion of 1 mug.kg(-1) over 10 min followed by an infusion of 0.7 mug.kg(-1).h(-1) for 50 min suggested that children arouse from sedation at a plasma concentration of 0.304 mug.l(-1).ConclusionsClearance in neonates is approximately one-third of that described in adults, consistent with immature elimination pathways. Maintenance dosing, which is a function of clearance, should be reduced in neonates and infants when using a target concentration approach.

21 keywords...

hide…